Ipamorelin 5mg + CJC-1295 No DAC 5mg (10mg)

£ 39.50 -

88 items in stock

–

Add to cart

Ipamorelin 5mg + CJC-1295 (No DAC) 5mg Blend - Research Peptides

This advanced research blend combines two extensively studied growth hormone–releasing peptides: Ipamorelin and CJC-1295 (No DAC). Ipamorelin is widely researched for its selective ghrelin receptor agonism and stimulation of growth hormone release without significant cortisol elevation, while CJC-1295 (No DAC) is studied for its short-acting growth hormone–releasing hormone (GHRH) analogue activity. Together, they create a synergistic formulation ideal for laboratory studies focused on pulsatile growth hormone signalling, recovery pathways, and metabolic research. New Wave Peptides supplies this 5mg + 5mg combination in high-purity, lyophilised form for laboratory research use only.

Download Third Party COA: Ipamorelin 5mg + CJC-1295 No DAC 5mg COA - Batch 20060/A
Batch 20060/A has been independently tested by Janoshik, verifying purity and peptide weight accuracy. Each vial is clearly labelled and traceable to its COA for full transparency and quality assurance.

Batch Number: 20060/A
Contents: Ipamorelin (5mg) + CJC-1295 No DAC (5mg)
Molecular Formula:
- Ipamorelin: C38H49N9O5
- CJC-1295 (No DAC): C152H252N44O42
Research Only: Yes
Purity: 99%+
Endotoxin Test: See Report
Form: Lyophilised Solid
Mixing Water Required: Yes

Usage and Storage:

Supplied as a lyophilised powder, this dual-peptide blend should be stored in a cool, dry place away from direct sunlight. Once reconstituted with sterile or bacteriostatic water, refrigerate and use within the recommended research time period for optimal stability.

Peptide Mixing Notes

Ensure both peptides and reconstitution solution are at room temperature before mixing. Slowly introduce the water down the inside of the vial and gently swirl—do not shake—to preserve peptide integrity and ensure proper dissolution.